Literature DB >> 10388743

Probing the structural changes in the light chain of human coagulation factor VIIa due to tissue factor association.

L Perera1, T A Darden, L G Pedersen.   

Abstract

The crystallographic structure of human coagulation factor VIIa/tissue factor complex bound with calcium ions was used to model the solution structure of the light chain of factor VIIa (residues 1-142) in the absence of tissue factor. The Amber force field in conjunction with the particle mesh Ewald summation method to accommodate long-range electrostatic interactions was used in the trajectory calculations. The estimated TF-free solution structure was then compared with the crystal structure of factor VIIa/tissue factor complex to estimate the restructuring of factor VIIa due to tissue factor binding. The solution structure of the light chain of factor VIIa in the absence of tissue factor is predicted to be an extended domain structure similar to that of the tissue factor-bound crystal. Removal of the EGF1-bound calcium ion is shown by simulation to lead to minor structural changes within the EGF1 domain, but also leads to substantial relative reorientation of the Gla and EGF1 domains.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10388743      PMCID: PMC1300315          DOI: 10.1016/S0006-3495(99)76875-X

Source DB:  PubMed          Journal:  Biophys J        ISSN: 0006-3495            Impact factor:   4.033


  67 in total

1.  The role of phospholipids and the factor VII Gla-domain in the interaction of factor VII with tissue factor.

Authors:  P Wildgoose; T Jørgensen; Y Komiyama; T Nakagaki; A Pedersen; W Kisiel
Journal:  Thromb Haemost       Date:  1992-06-01       Impact factor: 5.249

2.  Severe factor VII deficiency caused by mutations abolishing the cleavage site for activation and altering binding to tissue factor.

Authors:  S Chaing; B Clarke; S Sridhara; K Chu; P Friedman; W VanDusen; H R Roberts; M Blajchman; D M Monroe; K A High
Journal:  Blood       Date:  1994-06-15       Impact factor: 22.113

3.  How an epidermal growth factor (EGF)-like domain binds calcium. High resolution NMR structure of the calcium form of the NH2-terminal EGF-like domain in coagulation factor X.

Authors:  M Selander-Sunnerhagen; M Ullner; E Persson; O Teleman; J Stenflo; T Drakenberg
Journal:  J Biol Chem       Date:  1992-09-25       Impact factor: 5.157

4.  Tissue factor-dependent autoactivation of human blood coagulation factor VII.

Authors:  M Yamamoto; T Nakagaki; W Kisiel
Journal:  J Biol Chem       Date:  1992-09-25       Impact factor: 5.157

5.  The effect of aspartate hydroxylation on calcium binding to epidermal growth factor-like modules in coagulation factors IX and X.

Authors:  M S Sunnerhagen; E Persson; I Dahlqvist; T Drakenberg; J Stenflo; M Mayhew; M Robin; P Handford; J W Tilley; I D Campbell
Journal:  J Biol Chem       Date:  1993-11-05       Impact factor: 5.157

6.  Trans-cis isomerization of proline 22 in bovine prothrombin fragment 1: a surprising result of structural characterization.

Authors:  L Perera; T A Darden; L G Pedersen
Journal:  Biochemistry       Date:  1998-08-04       Impact factor: 3.162

7.  Solution structure of the N-terminal EGF-like domain from human factor VII.

Authors:  A Muranyi; B E Finn; G P Gippert; S Forsén; J Stenflo; T Drakenberg
Journal:  Biochemistry       Date:  1998-07-28       Impact factor: 3.162

8.  Molecular dynamics simulation of bovine prothrombin fragment 1 in the presence of calcium ions.

Authors:  N Hamaguchi; P Charifson; T Darden; L Xiao; K Padmanabhan; A Tulinsky; R Hiskey; L Pedersen
Journal:  Biochemistry       Date:  1992-09-22       Impact factor: 3.162

9.  A novel congenital haemostatic defect: combined factor VII and factor XI deficiency.

Authors:  C Bérubé; F A Ofosu; J G Kelton; M A Blajchman
Journal:  Blood Coagul Fibrinolysis       Date:  1992-08       Impact factor: 1.276

10.  The interaction of human factor VIIa with tissue factor.

Authors:  S Krishnaswamy
Journal:  J Biol Chem       Date:  1992-11-25       Impact factor: 5.157

View more
  3 in total

1.  Modeling zymogen protein C.

Authors:  L Perera; C Foley; T A Darden; D Stafford; T Mather; C T Esmon; L G Pedersen
Journal:  Biophys J       Date:  2000-12       Impact factor: 4.033

2.  Structure and dynamics of zymogen human blood coagulation factor X.

Authors:  Divi Venkateswarlu; Lalith Perera; Tom Darden; Lee G Pedersen
Journal:  Biophys J       Date:  2002-03       Impact factor: 4.033

3.  Association of a Variant in VWA3A with Response to Anti-Vascular Endothelial Growth Factor Treatment in Neovascular AMD.

Authors:  Michelle Grunin; Gala Beykin; Elior Rahmani; Regev Schweiger; Gal Barel; Shira Hagbi-Levi; Sarah Elbaz-Hayoun; Batya Rinsky; Michal Ganiel; Shai Carmi; Eran Halperin; Itay Chowers
Journal:  Invest Ophthalmol Vis Sci       Date:  2020-02-07       Impact factor: 4.799

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.